We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byKennedy Langhorn
Modified over 2 years ago
© Crown copyright 2009 Safeguarding public health Vigilance guidance for specific devices Tony Sant/Andy Crosbie – MHRA Presentation to the closed session of the Expert Group on Vigilance for Medical Devices – 15 Nov 2012
© Crown copyright 2009 Background MHRA has for some years issued advice on vigilance reporting for specific types of devices. Guidance is aimed at manufacturers and gives advice on notifying the MHRA of adverse incidents involving specific types of CE-marked medical devices under the medical devices vigilance system. Guidance is intended to facilitate uniform application and implementation of Medical Devices Directive 93/42/EEC. It is supplementary to (and should be read in conjunction with) the latest version of European Commission Guidelines on the Medical Devices Vigilance System - MEDDEV 2.12-1
© Crown copyright 2009 UK device specific vigilance guidance VG 01Joint replacement implants - July 2010 VG 02Artificial heart valves - Nov 2008 VG 03Breast implants - Oct 2009 VG 04Coronary stents - Mar 2009 VG 05IVD blood glucose meters for POCT or home use - Dec 2008 VG 06Inferior vena cava (IVC) filters- Mar 2009 VG 07Intra-ocular lenses- Jun 2009 VG 08Neurostimulators- Dec 2009 VG 09Cardiac Ablation Catheters- July 2010 See: http://www.mhra.gov.uk/Publications/Regulatoryguidance/Devices/ Vigilanceguidanceforspecificdevices/index.htm
© Crown copyright 2009 What do the device specific vigilance guidance documents do? They provide technical / clinical detail to supplement the general guidance on vigilance reporting given in MEDDEV 2.12-1 Each MHRA guidance document lists the major recognised types of adverse incident associated with each specific type of medical device and then gives MHRAs opinion on whether it is or is not usually reportable under vigilance as a malfunction or deterioration in the characteristics and/or performance of the device
© Crown copyright 2009 Summary table (see VG 06) of reportable/non- reportable individual adverse incidents under the vigilance system for inferior vena cava filters Summary table (see VG 06) of reportable/non- reportable individual adverse incidents under the vigilance system for inferior vena cava filters Note – for illustrative purposes only, this is not an exhaustive list Reportable Complications during deployment and placement Perforation/erosion Partial or multiple fractures Device migration Progressive tilting/angulation Recurrent/fatal pulmonary embolism Retrieval difficulties Labelling deficiencies MRI induced events Unanticipated events Generally non-reportable Vascular access and device placement related problems Inferior vena cava thrombosis/occlusion Endothelialisation IVC wall penetration Infection Adverse reaction
© Crown copyright 2009 Periodic summary reporting and trend reports MEDDEV 2.12-1 includes provision for manufacturers to undertake periodic summary reporting and to submit trend reports to national competent authorities Device specific vigilance guidance can be used to provide guidance on types of adverse incidents which may be suitable for these types of reporting (see for example VG 04 on coronary stents)
© Crown copyright 2009 Why should European device specific vigilance guidance be developed? Device specific vigilance guidance would supplement the general guidance in MEDDEV 2.12-1 on a Europe- wide basis Improve co-ordination of advice to industry and prepare for centralised reporting Harmonise use of PSRs and Trend reports in specific areas Minimise effort by concentrating on the lists of incident types to report and not to report and when to use Trend and PSR reports The Commission and Member States are expected to improve co- ordination (Dalli immediate action plan) Now that the MD Regulations have been proposed (Sept 2012) a simple programme of development could begin
© Crown copyright 2009 Next steps Propose Vigilance MDEG discusses and agrees 1 or 2 device specific guidance documents per meeting
© Crown copyright 2009 Safeguarding public health Thanks for listening
Medical Devices The current legislative and administrative structure.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 107.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 28.
Comparison GHTF/SG5/N5:2012 vs. MEDDEV 2.7/3:2010
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 58.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 75.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 40.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 116.
EU Vigilance New Manufacturer Incident Report Form Piloting arrangements.
CE marking Catriona Blake Team Manager, Imaging, acute and community care.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 44.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 101.
And the provisions of….. the Medical Devices Regulations Medical Devices Agency.
American Society Chapter 07.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 112.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 38.
Malta Standards Authority
Agenda The role of MHRA, Hospitals and the Manufacturer
© Safeguarding public health Implementing Medical Device Regulation and Maintaining Patient Safety Name Nicola Lennard Date October 2011.
1 Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 29.
CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.
Halifax, 31 Oct – 3 Nov 2011ICT Accessibility For All GTSC-9 Summary Glenn Parsons, GTSC-9 Chair, ISACC Document No: GSC16-CL-04 Source: GTSC-9 Contact:
Chapter 1 Image Slides Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
Stakeholder Involvement Program to Establish New and Better Hazardous Waste Treatment Facilities in WA 3c web: telephone: (08)
Medical Devices Regulation in the European Union Albuquerque - 10 April 2012 Emmanuel Grimaud Perfea Innovation Lyon, France – Albuquerque, NM
YearQuarter 1 (Jun - Aug) Quarter 2 (Sep - Nov) Quarter 3 (Dec – Feb) Quarter 4 (Mar – May) 05 – – – –
The European Qualifications Framework (EQF)
Infrastructure Planning Commission Workshop 2a Working with the IPC: Guidance and issues for statutory consultees.
Principles and Management
LP Seminar – Madrid – 20 October 2008 EUROPEAN REGIONAL DEVELOPMENT FUND REPORTING & MONITORING PROCEDURES Lead Partner Seminar Madrid, 20 October 2008.
© Copyright, The Joint Commission 2015 National Patient Safety Goals.
Joint Commission Management of Human Resources Leadership Meeting September 22, 2010.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
2014 National Patient Safety Goals
Revision of the Medical Device Directives The case of ‘Borderline’ Products used in a self-care context 48th AESGP Annual Meeting Nice, 6-8 June 2012 Laurent.
The Bologna Process and QA in 2020: Priorities for ENQA Tibor Szanto Vice-President, ENQA Brussels, 3 June 2009.
Workshop on conformity assessment procedures and certification of medical devices INT MARKT Kyiv, November 2011 Conformity assessment of medical.
© Safeguarding public health BIOABSORBABLE STENTS: REGULATORY ISSUES DR SUSANNE LUDGATE Clinical Director Medicines and Healthcare products Regulatory.
Health and Safety Executive Health and Safety Executive Construction (Design and Management) Regulations 2007 Training Package Session 1- Overview Version:
Czech Office for Standards, Metrology and Testing Prague/Czech Republic.
15. Oktober Oktober Oktober 2012.
1 Security-related internal market measures on explosives FEEM AGM, Brussels, 5 June 2013 Julian Foley Desk Officer – Civil explosives and pyrotechnic.
Draft Legislation on Reform of Provision of Young People and Children with SEN Children and Families Act.
Harmonisation of the European Reporting Framework COREP
Bard Denali Inferior Vena Cava Filter Fracture and Embolization Resulting in Cardiac Tamponade: A Device Failure Analysis William T. Kuo, MD, Scott W.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 1 – Free movement of goods Bilateral.
PRINCIPLES OF FUNDRAISING
The regulation of medical devices in Australia. Overview Comparing medicines and medical devices What is a medical device? Statistics on patients requiring.
The Joint Commission Chapter update: Waived Testing
MEDDEV1 MEDDEV és NB-MED dokumentumok Dárday Vilmos orvostechnikai szakértő 2010.
© 2017 SlidePlayer.com Inc. All rights reserved.